ARIA

Thymogen

Not FDA Approved✓ WADA Permitted

Alpha-Glu-Trp

anti agingExperimentalThymic Peptide Bioregulator

Synthetic dipeptide bioregulator from thymic extract. Modulates immune function and anti-aging via thymic regeneration and telomere maintenance. Used in Russian clinical practice for age-related immune decline.

Confidence
55%
Half-Life 2-4 hours
Cost ~$85/mo
Quick Reference
RouteSC injection or intranasal
MechanismBinds thymic epithelial cells, stimulating T-cell maturation. Upregulates telome...
SequenceGlu-Trp
Mol. Weight333.34 Da
Reviewed2026-07-15

Mechanism of Action

Binds thymic epithelial cells, stimulating T-cell maturation. Upregulates telomerase in lymphocytes. Reduces IL-6, TNF-alpha. Enhances NK cell activity.

Dosing Protocol

100 mcg SC daily for 10 days, repeat quarterly

Key Studies

2005

Thymogen in geriatric immune deficiency

PMID 15834921clinical_trial
2016

Telomere lengthening by thymic peptides

PMID 26769234preclinical

Adverse Effects

Contraindications

    Storage

    2-8°C. Protect from light. Use within 30 days.

    Clinical Applications

    • Age-related immune decline
    • chronic fatigue
    • post-chemo recovery
    • telomere maintenance